ARKEMA (AKE.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:AKE - FR0010313833 - Common Stock
51 EUR
-0.05 (-0.1%)
We assign a fundamental rating of 4 out of 10 to AKE. AKE was compared to 68 industry peers in the Chemicals industry. AKE has only an average score on both its financial health and profitability. AKE is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
AKE had positive earnings in the past year.
AKE had a positive operating cash flow in the past year.
In the past 5 years AKE has always been profitable.
In the past 5 years AKE always reported a positive cash flow from operatings.
1.2 Ratios
AKE has a Return On Assets (1.51%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 2.90%, AKE is in line with its industry, outperforming 53.33% of the companies in the same industry.
With a Return On Invested Capital value of 3.44%, AKE perfoms like the industry average, outperforming 48.00% of the companies in the same industry.
AKE had an Average Return On Invested Capital over the past 3 years of 5.57%. This is in line with the industry average of 7.01%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROIC | 3.44% |
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
1.3 Margins
Looking at the Profit Margin, with a value of 2.22%, AKE is in line with its industry, outperforming 54.67% of the companies in the same industry.
In the last couple of years the Profit Margin of AKE has declined.
AKE's Operating Margin of 6.35% is in line compared to the rest of the industry. AKE outperforms 57.33% of its industry peers.
AKE's Operating Margin has declined in the last couple of years.
AKE has a Gross Margin of 19.02%. This is in the lower half of the industry: AKE underperforms 73.33% of its industry peers.
AKE's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% |
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AKE is still creating some value.
The number of shares outstanding for AKE has been increased compared to 1 year ago.
The number of shares outstanding for AKE has been reduced compared to 5 years ago.
Compared to 1 year ago, AKE has a worse debt to assets ratio.
2.2 Solvency
AKE has an Altman-Z score of 1.86. This is not the best score and indicates that AKE is in the grey zone with still only limited risk for bankruptcy at the moment.
AKE's Altman-Z score of 1.86 is on the low side compared to the rest of the industry. AKE is outperformed by 73.33% of its industry peers.
The Debt to FCF ratio of AKE is 16.70, which is on the high side as it means it would take AKE, 16.70 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 16.70, AKE is in line with its industry, outperforming 52.00% of the companies in the same industry.
AKE has a Debt/Equity ratio of 0.50. This is a neutral value indicating AKE is somewhat dependend on debt financing.
AKE has a Debt to Equity ratio (0.50) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Altman-Z | 1.86 |
ROIC/WACC0.71
WACC4.84%
2.3 Liquidity
A Current Ratio of 2.73 indicates that AKE has no problem at all paying its short term obligations.
AKE has a Current ratio of 2.73. This is amongst the best in the industry. AKE outperforms 82.67% of its industry peers.
A Quick Ratio of 1.92 indicates that AKE should not have too much problems paying its short term obligations.
AKE has a better Quick ratio (1.92) than 85.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 |
3. Growth
3.1 Past
AKE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.40%.
Measured over the past 5 years, AKE shows a small growth in Earnings Per Share. The EPS has been growing by 0.10% on average per year.
Looking at the last year, AKE shows a small growth in Revenue. The Revenue has grown by 0.32% in the last year.
AKE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.78% yearly.
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%
3.2 Future
AKE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.13% yearly.
The Revenue is expected to grow by 1.37% on average over the next years.
EPS Next Y-42.01%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
EPS Next 5Y-2.13%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.37%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 9.90 indicates a reasonable valuation of AKE.
Based on the Price/Earnings ratio, AKE is valued cheaper than 90.67% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.92, AKE is valued rather cheaply.
AKE is valuated reasonably with a Price/Forward Earnings ratio of 9.51.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 92.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.46, AKE is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.9 | ||
| Fwd PE | 9.51 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AKE is valued cheaper than 94.67% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 82.67% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.09 | ||
| EV/EBITDA | 4.42 |
4.3 Compensation for Growth
A cheap valuation may be justified as AKE's earnings are expected to decrease with -8.39% in the coming years.
PEG (NY)N/A
PEG (5Y)101.33
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
5. Dividend
5.1 Amount
AKE has a Yearly Dividend Yield of 7.06%, which is a nice return.
Compared to an average industry Dividend Yield of 2.51, AKE pays a better dividend. On top of this AKE pays more dividend than 93.33% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, AKE pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.06% |
5.2 History
The dividend of AKE is nicely growing with an annual growth rate of 6.80%!
Dividend Growth(5Y)6.8%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
129.52% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
The Dividend Rate of AKE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP129.52%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
EPA:AKE (12/24/2025, 7:00:00 PM)
51
-0.05 (-0.1%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners61.12%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap3.88B
Revenue(TTM)9.54B
Net Income(TTM)210.00M
Analysts71.43
Price Target63.94 (25.37%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.06% |
Yearly Dividend3.46
Dividend Growth(5Y)6.8%
DP129.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.64%
Min EPS beat(2)-8.67%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-18.44%
Max EPS beat(4)-1.73%
EPS beat(8)3
Avg EPS beat(8)-4.83%
EPS beat(12)7
Avg EPS beat(12)1.09%
EPS beat(16)11
Avg EPS beat(16)10.55%
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)8
Avg Revenue beat(16)0.76%
PT rev (1m)-3.09%
PT rev (3m)-18.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-28.26%
EPS NY rev (1m)-9.51%
EPS NY rev (3m)-15.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.74%
Revenue NY rev (1m)-0.44%
Revenue NY rev (3m)-2.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.9 | ||
| Fwd PE | 9.51 | ||
| P/S | 0.41 | ||
| P/FCF | 17.09 | ||
| P/OCF | 3.82 | ||
| P/B | 0.54 | ||
| P/tB | 1.81 | ||
| EV/EBITDA | 4.42 |
EPS(TTM)5.15
EY10.1%
EPS(NY)5.36
Fwd EY10.52%
FCF(TTM)2.98
FCFY5.85%
OCF(TTM)13.36
OCFY26.19%
SpS124.15
BVpS95.11
TBVpS28.16
PEG (NY)N/A
PEG (5Y)101.33
Graham Number104.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROCE | 4.88% | ||
| ROIC | 3.44% | ||
| ROICexc | 3.86% | ||
| ROICexgc | 7.22% | ||
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% | ||
| FCFM | 2.4% |
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexgc growth 3Y-19.33%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score5
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Debt/EBITDA | 2.56 | ||
| Cap/Depr | 95.75% | ||
| Cap/Sales | 8.36% | ||
| Interest Coverage | 17.14 | ||
| Cash Conversion | 71.35% | ||
| Profit Quality | 108.1% | ||
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 1.86 |
F-Score5
WACC4.84%
ROIC/WACC0.71
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
EPS Next Y-42.01%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
EPS Next 5Y-2.13%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.37%
EBIT growth 1Y-21.16%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year42.37%
EBIT Next 3Y16.8%
EBIT Next 5Y12.34%
FCF growth 1Y-64.53%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-26.48%
OCF growth 3Y7%
OCF growth 5Y-2.92%
ARKEMA / AKE.PA FAQ
What is the ChartMill fundamental rating of ARKEMA (AKE.PA) stock?
ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.
What is the valuation status of ARKEMA (AKE.PA) stock?
ChartMill assigns a valuation rating of 7 / 10 to ARKEMA (AKE.PA). This can be considered as Undervalued.
How profitable is ARKEMA (AKE.PA) stock?
ARKEMA (AKE.PA) has a profitability rating of 4 / 10.
What are the PE and PB ratios of ARKEMA (AKE.PA) stock?
The Price/Earnings (PE) ratio for ARKEMA (AKE.PA) is 9.9 and the Price/Book (PB) ratio is 0.54.
How financially healthy is ARKEMA?
The financial health rating of ARKEMA (AKE.PA) is 5 / 10.